10 Buzzing AI Health Stocks 

Page 3 of 10

8. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

Number of Hedge Fund Holders: 57   

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. Regeneron is at the forefront of using AI to expedite drug discovery, particularly in its genetic research programs. The company’s AI tools are used to identify genetic mutations linked to specific diseases, accelerating the development of personalized treatments. Regeneron’s AI-driven Regeneron Genetics Center is one of the world’s largest genetic research databases, providing a wealth of data for developing new therapies.

Regeneron’s 2023 financials reflect the success of its AI integration, with the company’s genetic research capabilities, enhanced by AI, have helped drive significant growth, particularly in the development of therapies for retinal diseases and cancer. Regeneron’s ongoing AI investments are expected to support continued revenue growth in the coming years.

Page 3 of 10